## OLLI: Ollie's Bargain Outlet Holdings, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -3.5% below STRENGTH zone (4.0-10.0%); PEG 2.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($111.97)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Exploring Analyst Estimates for Ollie's Bargain Outlet (OLLI) Q3 Earnings, Beyond Revenue and EPS**
- Source: Yahoo Finance | 20251205T043447 | Bullish | Relevance: 100%
- Wall Street analysts project that Ollie's Bargain Outlet (OLLI) will report a 22.4% year-over-year increase in Q3 earnings to $0.71 per share, with revenues expected to rise 19% to $615.68 million. Beyond financial figures, analysts estimate the company will end the period with 640 stores, having opened 27 new stores. OLLI currently holds a Zacks Rank #2 (Buy), indicating potential outperformance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | UBS | $141 | $140 | +1% |
| 2025-11-24 | Citigroup | $150 | $154 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | UBS | main | Neutral |
| 2025-11-24 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.12M) |
| Sells | 5 ($0.65M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- FMR, LLC: 12.7% (-3.2%)
- Vanguard Group Inc: 9.4% (-0.8%)
- Blackrock Inc.: 8.8% (+0.4%)
- Kayne Anderson Rudni: 6.7% (-7.4%)
- Wasatch Advisors LP: 6.0% (-9.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.08 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (2.5x). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.9B |
| Beta | 0.45 |
| 52W Range | $94.88 - $141.74 |
| Short Interest | 7.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.08 |
| Forward P/E | 27.1 |
| Current P/E | 31.4 |
| YoY Growth | 15.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.7%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20). RSI neutral at 47. Elevated volume (1.3x 20MA), institutional activity likely. OFD pattern: +MUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.53% (CS: 23) | Weak |
| RSI_14 | 47.3 | Neutral |
| MACD Histogram | -0.25 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.976x | Below |
| vs SMA200 | 1.002x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $121.33
- **Stop Loss:** $111.97 (7.7% risk)
- **Target:** $130.69 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 53
- **Position Value:** $6,430.49
- **Portfolio %:** 6.43%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.73 | $0.75 | +2.4% |
| 2025Q3 | $0.93 | $0.99 | +6.8% |
| 2025Q2 | $0.71 | $0.75 | +5.8% |
| 2025Q1 | $1.19 | $1.19 | -0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*